Remove 2030 Remove Pharma Companies Remove Pharmaceuticals
article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources. To address these challenges, many companies outsource their clinical trials to contract research organizations (CROs) with established protocols, global reach, and therapeutic area expertise1.

article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. share of global pharma revenues, according to analysts Statistica 1. In 2022, the continent held a 22.4%

Drugs 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

European drug discovery and development: success stories

Drug Discovery World

until 2030. According to Steve Bates OBE, Chief Executive of the BIA: “The UK is a global hub for life sciences, with a world leading academic base, global pharmaceutical players, an increasing manufacturing footprint and a thriving pipeline of innovative SMEs and entrepreneurs.” . Lu Rahman highlights some of the key players. .

article thumbnail

Scandinavia: insight into opportunities for drug discovery

Drug Discovery World

Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Sweden remains Scandinavia’s powerhouse market for pharmaceutical research and development. Sweden remains Scandinavia’s powerhouse market for pharmaceutical research and development.

Science 130
article thumbnail

India: Why is the country ramping up drug discovery research?

Drug Discovery World

In the global pharmaceuticals market, India ranks third worldwide for production by volume and the domestic pharmaceutical market is expected to reach US$120-130 billion by 2030 1. Similarly, The Times of India says that branded generic medicines have “long fuelled India’s pharmaceutical exports” 4.

Research 130
article thumbnail

Why more work is needed to fight antimicrobial resistance

Drug Discovery World

This is especially important given the lack of attention the AMR space has generated from the major pharmas. And it won’t be a quick move back into this market, by those big companies, but I think we need to keep pushing them.” The healthcare sector is trying to make it more appealing for pharma companies to develop antimicrobials.

Vaccine 147